(Rockefeller University Press) A new study in the Sept. 6 issue of the Journal of Cell Biology helps define the role of an important ciliary protein, CEP290. The results could be applied toward targeted gene therapy in cilia-related diseases.
Read »Navigation
User login
Visit the BiotechMashup Blog